Skip to content

DOKTER TYRONE DEVOLDER

Active
Private limited companyfounded 2018active for 8 yearsMinister Liebaertlaan 7, 8500 Kortrijk, BelgiumKBO/BCE: BE 0697.804.637
Summary

DOKTER TYRONE DEVOLDER has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,000 and a net result of €100,238. Equity has been shrinking by about 22% per year since 2019. If that trend continues, it turns negative around financial year 2026. Its solvency ranks better than 6% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 11-06-2018 Normal situation
Activity
General medical practice NACE 86210and 1 other
Establishment unit
2.276.703.925 8500 Kortrijk, since 11-06-2018
Financial year end
30 June
Peppol
Reachable since 27-11-2025

Board and ownership

Board
  • Devolder TyroneDirector · since 07-06-2018
Shareholders
  • enige aandeelhouderact of 28-04-2022

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts to 30-06-2025
Gross margin
€149,261
▲ 12.6%
Turnover
≈ €270,000
estimated
Profit
€100,238
▲ 3.8%
Equity
€3,000
▼ 86.0%
Total assets
€211,300
▲ 21.5%
Staff
0.2 FTE
Score breakdownraises riskEquity €3,000 (1.4% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €211,300Liquidity: current ratio 0.85, cash €91,779Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 28% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 26-11
equity 1.4% of total assets
Liquidity 50-2
short-term debt 98.4% · cash 43.4%
Profitability 100=
return on assets 47.4%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1%lowest value 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: 0.1%▲ +0.1 percentage points vs 12-2025highest value 02-2026: < 0.1%▼ -0.1 percentage points vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 6% of them on solvency, 20% on liquidity, 80% on profitability and 6% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Equity €3,000 (1.4% of total assets)
NBB · annual accounts
lowers risk · Size: total assets €211,300
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Liquidity: current ratio 0.85, cash €91,779
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 6% of 20720 sector peers (2025).
NBB · sector comparison
Position among 20720 sector peers
Solvency
better than 6%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 30-01-2026, 1 day ahead of the deadline.
NBB · 7 filings
Deviation from the deadline
2025
1 day early
2024
28 days late
2023
41 days early
2022
49 days early
2021
on the day
2020
1 day late
2019
1 day early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 9 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 30 January (4 of the last 5 accounts filed within 40 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
30-06-2026 year end05-11-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Lower solvency than 94% of companies in human healthsector median 63.0% · 20,720 companies 1.4% View
  • Positive: 7 profitable years in a rowprofit 2025: €100,238 7 years View

Recent changes

  1. · Gazette deed Amendment of the articles · Legal-form changeenige aandeelhouder holds all the shares
  2. · Gazette deed Incorporation
All 11 events

Comparable companies

These companies have the same main activity as DOKTER TYRONE DEVOLDER: general medical practice (NACE 86210). They are comparable in size and age: total assets between €195,000 and €234,000, founded between 2017 and 2018.

CompanyTotal assetsGross margin
DOKTER TYRONE DEVOLDER Kortrijk€211,300€149,261
Dr. Pieterjan Debbaut Kortrijk€225,834€146,802
Dr. Olivier Vercruysse huisarts Oostrozebeke€212,759€140,424
Dr. Gert-Jan Aelvoet Roeselare€233,819€164,799
Dokter Vanduynslager Tine Roeselare€195,040€138,021
Dokter Lampens Inge, huisarts Nazareth-De Pinte€197,103€148,269
THOCOR Herk-de-Stad€196,245€157,840
Full comparison

Key facts about DOKTER TYRONE DEVOLDER

What is the company number of DOKTER TYRONE DEVOLDER?
The company number of DOKTER TYRONE DEVOLDER is 0697.804.637. The VAT number is the same number with BE in front: BE 0697.804.637.
Where is DOKTER TYRONE DEVOLDER based?
The registered office is at Minister Liebaertlaan 7, 8500 Kortrijk.Company details
What does DOKTER TYRONE DEVOLDER do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of DOKTER TYRONE DEVOLDER?
The legal form of DOKTER TYRONE DEVOLDER is Private limited company (BV).
When was DOKTER TYRONE DEVOLDER founded?
DOKTER TYRONE DEVOLDER was founded on 11-06-2018.
Is DOKTER TYRONE DEVOLDER still active?
Yes, DOKTER TYRONE DEVOLDER is an active enterprise in the KBO register.
How many employees does DOKTER TYRONE DEVOLDER have?
DOKTER TYRONE DEVOLDER had an average of 0.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of DOKTER TYRONE DEVOLDER?
The turnover in financial year 2025 is ≈ €270,000. This figure is estimated from the gross margin of €149,261 and 30 comparable companies (NACE 86210). It probably lies between €220,000 and €340,000.
Is DOKTER TYRONE DEVOLDER profitable?
In financial year 2025, DOKTER TYRONE DEVOLDER made a profit of €100,238.
Where can I find the annual accounts of DOKTER TYRONE DEVOLDER?
DOKTER TYRONE DEVOLDER filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DOKTER TYRONE DEVOLDER due?
DOKTER TYRONE DEVOLDER must file the annual accounts for financial year 2026 by 31-01-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.